Multiple Myeloma

Showing NaN - NaN of 90

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)

Not yet recruiting
  • Multiple Myeloma
  • idecabtagene vicleucel
  • +3 more
  • Gilbert, Arizona
  • +107 more
Sep 26, 2023

Multiple Myeloma Trial in Saint Louis (Care transition, No care transition)

Not yet recruiting
  • Multiple Myeloma
  • Care transition
  • No care transition
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 30, 2023

Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Myeloma-Associated Amyloidosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 6, 2023

Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (clonoSEQ

Recruiting
  • Acute Lymphoblastic Leukemia, Adult B-Cell
  • +3 more
  • clonoSEQ Assay
  • Stanford, California
  • +15 more
Jan 30, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +189 more
Jan 27, 2023

Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

Completed
  • Multiple Myeloma
  • Birmingham, Alabama
  • +60 more
Jan 24, 2023

Multiple Myeloma Trial in Worldwide (Modakafusp Alfa, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Gilbert, Arizona
  • +40 more
Jan 23, 2023

Collection of Tissue Samples for Cancer Research

Recruiting
  • Neoplasms
  • +3 more
  • Biopsy
  • Atlanta, Georgia
  • +9 more
Jan 23, 2023

Multiple Myeloma, Non-Hodgkin Lymphoma, B-Cell Lymphoma Trial in Korea, Republic of, United States (Tiragolumab,

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Denver, Colorado
  • +12 more
Jan 19, 2023

Multiple Myeloma Trial in Worldwide (JNJ-68284528, Pomalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +87 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +26 more
Jan 17, 2023

Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Daratumumab IV
  • +3 more
  • Birmingham, Alabama
  • +211 more
Jan 17, 2023

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Duarte, California
  • +9 more
Jan 11, 2023

Real-life Current Standards of Care in Relapsed and/or

Completed
  • Multiple Myeloma
  • No intervention
  • Tucson, Arizona
  • +85 more
Dec 20, 2022

Multiple Myeloma Trial in Worldwide (Carfilzomib 20 mg/m^2, Carfilzomib 70 mg/m^2, Dexamethasone 40 mg)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib 20 mg/m^2
  • +4 more
  • Gilbert, Arizona
  • +107 more
Dec 20, 2022

Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +8 more
  • Birmingham, Alabama
  • +59 more
Dec 13, 2022

Multiple Myeloma, Lymphoma, Non-Hodgkin's Trial in United States (CFT7455, Dexamethasone Oral)

Recruiting
  • Multiple Myeloma
  • Lymphoma, Non-Hodgkin's
  • Phoenix, Arizona
  • +12 more
Dec 12, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Birmingham, Alabama
  • +25 more
Dec 9, 2022

Multiple Myeloma Trial in Worldwide (Pomalidomide, Bortezomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Mobile, Alabama
  • +278 more
Dec 6, 2022

Bone Metastases, Lymphoma, Multiple Myeloma Trial in Saint Louis (Ketorolac, Normal saline, Acetaminophen)

Recruiting
  • Bone Metastases
  • +4 more
  • Saint Louis, Missouri
    Saint Louis University
Dec 6, 2022

Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)

Completed
  • Multiple Myeloma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 22, 2022

Multiple Myeloma Trial in Saint Louis (Isatuximab, Bendamustine, Prednisone)

Recruiting
  • Multiple Myeloma
  • Isatuximab
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 21, 2022

Multiple Myeloma Trial in Worldwide (ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone
  • Atlanta, Georgia
  • +25 more
Aug 31, 2022

Multiple Myeloma Trial in United States (SEA-BCMA, dexamethasone, pomalidomide)

Recruiting
  • Multiple Myeloma
  • Palo Alto, California
  • +10 more
Aug 24, 2022